Youjin Kim

Youjin Kim is Director of Downstream Process Development at Bionova Scientific.

Prior to joining Bionova, Youjin was in the engineering group at Samsung Biologics where she supported the overall facility design of a new 12X15KL bioreactor facility and led overall procurement, design, construction, and validation activities to implement 30 stainless steel bioreactors and 9 ATF systems.

She also led group efforts to qualify single-use vendors by performing technical audits. Before Sam-sung, Youjin led various upstream process development projects at Boehringer Ingelheim, including scale-up/scale-down studies from 2L to 12KL and equipment modifications to accommodate different operation modes for bioreactors.

Youjin started her career in MedImmune’s manufacturing team, where she supported the tech transfer of an egg-based influenza vaccines process into a new facility and was extensively trained in cGMP practices. At Medimmune, she also worked on upstream project development, including media development, optimization of chemostat and fed-batch processes, and scale-up experiments.

Youjin earned her M.S. Chemical Engineering at San Jose State University, her B.S. in Chemical Engineering with a Minor in Chemistry and Music at the University of California Berkeley.